Born and Refined in the OR

Designed by experts, validated by anesthesiologists

The TwitchView Train of Four Monitor is the Only Quantitative Monitor Proven to Eliminate Residual Paralysis4. 

We envision a world where residual neuromuscular blockade following surgery has been eliminated. Our goal is to make quantitative monitoring as routine and indispensable as pulse oximetry or continuous blood pressure monitoring—integrated into the workflow and guiding personalized drug administration.

Every Patient Deserves a Safe Recovery.

Meet The Team:

Dan Hoffman

Dan Hoffman

Director of Engineering

Dan Hoffman

Director of Engineering

Dan Hoffman has built a career designing medical devices across various industries. Prior to Blink, he worked as a design engineer in molecular diagnostics at a subsidiary of Sony. In 2016, Dan joined Blink, where he led the design of the TwitchView monitor and the TwitchView 2 system.

Returning in 2024 as Director of Engineering, he focuses on enhancing TwitchView and leading new product development. Dan holds a B.S. in Mechanical Engineering from the University of Colorado.

 

Chandler Lacy

Chandler Lacy

Director, QA/RA

Chandler Lacy

Director, QA/RA

Chandler joined Blink Device Company in 2023, bringing a wealth of experience in medical device product management, including R&D, manufacturing, and quality systems. He has worked with industry leaders like Medtronic and Boston Scientific, as well as innovative startups, on products such as HF electrosurgery, catheters, and spinal navigation. 

Niklas Mollenholt

Niklas Mollenholt

Director of Finance & Accounting

Niklas Mollenholt

Director of Finance & Accounting

Niklas was Managing Director of Finance at Seattle based engineering & design group Pensar Development prior to joining Blink in 2023.  He oversaw the smooth transfer of assets to Apple when Pensar was acquired in 2022.  

Taking a road less traveled into finance and accounting, Niklas graduated from University of Washington with a Bachelor of Science degree in Psychology.  Niklas got his CPA in 2018 and previously had accounting roles in manufacturing, performance art and in healthcare.

 

Cole Plunkett

Cole Plunkett

Director of Sales

Cole Plunkett

Director of Sales

Cole has started his career with a decade of success selling innovative medical technology. Prior to Blink, he led the implementation of perioperative and anesthesia technology with Oracle Cerner and spent almost 4 years selling and strategically leading some of the fastest growing advanced wound care technologies in the world with Urgo Medical. Since joining Blink in 2022, he has managed the South-Central region and was promoted to Director of Sales in 2025.
 
Cole received a BS in Biochemistry, Cum Laude, from the University of Arkansas.

Savino de Serio

Savino de Serio

Sr. International Sales Director

Savino de Serio

Sr. International Sales Director

Savino has worked in the medical industry since 1997. He brings experience working with leading companies such as Nellcor Puritan Bennett, Mallinckrodt, Tyco, Accriva Diagnostics and Werfen. He has a proven track record in international sales and extensive distribution management experience. Savino has supported the introduction and consolidation of brands across diverse international markets.


Savino earned his degree in Political Sciences and International Relation at the University of Pavia – Italy.

 

 

Austin Smith

Austin Smith

Manager of National Sales Training and Strategy

Austin Smith

Manager of National Sales Training and Strategy

Austin is a dynamic sales leader with proven expertise in strategic sales and management. Austin joined Blink in 2021 to lead the Midwest region, where he has driven multiple years of record setting growth for the company. Prior to Blink, he spent three years at Baxter, consistently ranking as a top sales representative. At Blink, Austin continues to manage the Midwest region while also shaping national sales strategies and expanding market presence.


Austin received a BS in Entrepreneurial Management from the University of Iowa in 2017.

 

Leslie Aberman

Leslie Aberman

Strategic Counsel & Business Affairs

Leslie Aberman

Strategic Counsel & Business Affairs

Leslie brings over 25 years of experience advising in the areas of corporate, intellectual property, and general business law within the biotech, pharma, and life sciences industries. Before joining Blink Device Company, she served as General Counsel at Cajal Neuroscience and, prior to Cajal, she served as VP of Intellectual Property and Legal Affairs at Neoleukin Therapeutics. She has also held legal counsel and intellectual property roles at the Infectious Disease Research Institute and Seattle Genetics. Leslie serves as a volunteer mediator with the Dispute Resolution Center of King County.

Leslie received a BS in Chemistry from Brown University and her JD from Columbia Law School.

Justin Hulvershorn

Justin Hulvershorn

CEO

Justin Hulvershorn

CEO

Justin has built his career at the intersection of medicine and engineering, co-founding two companies to bring his inventions into clinical practice. His first venture, Mirador Biomedical, was acquired by Centurion Medical Products in 2014. Earlier in his career, he served as Director of Research at Northstar Neuroscience, which went public in 2006 and was later acquired by St. Jude Medical.

Justin earned his M.D. and Ph.D. from the University of Pennsylvania, after studying Engineering (B.S.) at the University of Virginia.

 

Tom Archipley

Tom Archipley

Chairman

Tom Archipley

Chairman

Tom was formerly the President and CEO of Centurion Medical Products. Under Tom’s tenure as CEO, Centurion’s annual revenues doubled to $230 million. Tom sold Centurion to Medline Industries in 2017, and subsequently founded Blink to focus on developing and commercializing innovative medical devices.

Tom holds an MBA from the University of Texas at Austin and a BA in Economics from Denison University.

Designed and Manufactured in Seattle, Washington

Press Releases / News

Blink Device Company Celebrates Record-Breaking Year with Gratitude to Customers and Colleagues

Blink Device Company Celebrates Record-Breaking Year with Gratitude to Customers and Colleagues

Residual paralysis affects up to 40% of patients without quantitative monitoring. Learn what 0% residual paralysis looks like in clinical practice, ...

Read More →
TwitchView® Train of Four Monitor Used to Eliminate Residual Neuromuscular Blockade

TwitchView® Train of Four Monitor Used to Eliminate Residual Neuromuscular Blockade

A new Anesthesia & Analgesia study shows the TwitchView® TOF monitor eliminated post-operative residual neuromuscular blockade while reducing ...

Read More →
Emory Healthcare Deploys TwitchView™ Train-of-Four Monitor Systemwide

Emory Healthcare Deploys TwitchView™ Train-of-Four Monitor Systemwide

Emory Healthcare adopts the TwitchView® TOF monitor across all operating rooms, standardizing quantitative neuromuscular monitoring to improve safety ...

Read More →
Blink Device Company Announces TwitchView™ Quantitative Monitor for Neuromuscular Blockade is Now Compatible with Major Electronic Medical Records

Blink Device Company Announces TwitchView™ Quantitative Monitor for Neuromuscular Blockade is Now Compatible with Major Electronic Medical Records

Blink Device Company announces TwitchView™ quantitative TOF monitor integration with major EMR systems, improving patient safety and recovery through ...

Read More →
Blink Device Company Launches TwitchView™ Neuromuscular TOF Monitor at American Society of Anesthesia Meeting

Blink Device Company Launches TwitchView™ Neuromuscular TOF Monitor at American Society of Anesthesia Meeting

Blink Device Company launches TwitchView™ quantitative TOF monitor at ASA 2018, presenting clinical data confirming EMG equivalence to the ...

Read More →
Medical Device Manufacturer Blink Device Company Signs Distribution Agreement with KCPMED

Medical Device Manufacturer Blink Device Company Signs Distribution Agreement with KCPMED

Blink Device Company partners with KCPMED to distribute the TwitchView™ quantitative TOF monitor in South Korea, expanding global access to safer, ...

Read More →
Blink Device Company Receives CE Mark for TwitchView™ Quantitative Monitor for Neuromuscular Blockade

Blink Device Company Receives CE Mark for TwitchView™ Quantitative Monitor for Neuromuscular Blockade

Blink Device Company earns CE Mark for its TwitchView™ quantitative TOF monitor, bringing accurate EMG-based neuromuscular monitoring to Europe for ...

Read More →
Blink Device Company Announces TwitchView™ Quantitative Monitor for Neuromuscular Blockade is Now Compatible with Philips IntelliVue Patient Monitors

Blink Device Company Announces TwitchView™ Quantitative Monitor for Neuromuscular Blockade is Now Compatible with Philips IntelliVue Patient Monitors

Blink Device Company’s TwitchView™ TOF monitor now integrates with Philips IntelliVue Patient Monitors, delivering real-time EMG data and seamless ...

Read More →

Residual Paralysis Stops Here.

Connect with Blink Anesthesia to explore TwitchView® for your institution.